The half-day visit on the site of Louvain-la-Neuve, (Belgium) gave the opportunity to illustrate the achievements of our chemical industry in the containment of chemical operations, waste reduction and minimal emissions to the environment. CEFIC officials and stakeholders visited with great interest the Minakem facility, a manufacturer of highly potent ingredients for oncology drugs.
In addition, the debate also tackled the complexity of the international pharmaceutical supply chain, the risk of drug shortages on the EU market and the need to support and strengthen the industrial excellence and global competitiveness of the EU-based factories.
Frédéric Gauchet, President and founder of the Minafin Group says “We are happy to welcome this delegation and have the opportunity to show what a manufacturer of active pharmaceutical ingredients is doing to continuously improve the quality of the drugs, what we have accomplished to implement the working conditions which are right for our customers, our employees, and the environment. It is also important for us to explain EU Authorities all the challenges faced by our domestic industry to withstand the international competition which is not subject to the same level of operating requirements as in EU.’
Marco Mensink, CEFIC Secretary-General states: ‘Our delegation was very interested in discovering the real-life work conditions of such a factory. We are convinced that it is extremely beneficial for our industry to work together with EU authorities and stakeholders to support the Commission’s ambition, be it for their zero-pollution agenda or the reduction of the risk of shortages of critical pharmaceuticals. Their goals cannot be attained without a strong and globally competitive EU industry’
For more information, contact Sylvie Boone by email sylvie.boone@minafin.com or by phone: +32.10.23.86.12